• 1,201 days Will The ECB Continue To Hike Rates?
  • 1,201 days Forbes: Aramco Remains Largest Company In The Middle East
  • 1,203 days Caltech Scientists Succesfully Beam Back Solar Power From Space
  • 1,603 days Could Crypto Overtake Traditional Investment?
  • 1,608 days Americans Still Quitting Jobs At Record Pace
  • 1,610 days FinTech Startups Tapping VC Money for ‘Immigrant Banking’
  • 1,613 days Is The Dollar Too Strong?
  • 1,613 days Big Tech Disappoints Investors on Earnings Calls
  • 1,614 days Fear And Celebration On Twitter as Musk Takes The Reins
  • 1,616 days China Is Quietly Trying To Distance Itself From Russia
  • 1,616 days Tech and Internet Giants’ Earnings In Focus After Netflix’s Stinker
  • 1,620 days Crypto Investors Won Big In 2021
  • 1,620 days The ‘Metaverse’ Economy Could be Worth $13 Trillion By 2030
  • 1,621 days Food Prices Are Skyrocketing As Putin’s War Persists
  • 1,623 days Pentagon Resignations Illustrate Our ‘Commercial’ Defense Dilemma
  • 1,624 days US Banks Shrug off Nearly $15 Billion In Russian Write-Offs
  • 1,627 days Cannabis Stocks in Holding Pattern Despite Positive Momentum
  • 1,628 days Is Musk A Bastion Of Free Speech Or Will His Absolutist Stance Backfire?
  • 1,628 days Two ETFs That Could Hedge Against Extreme Market Volatility
  • 1,630 days Are NFTs About To Take Over Gaming?
Mark Valek

Mark Valek

Mark is founding partner and investment manager of Incrementum AG. Together with Ronald Stoeferle he manages a global macro fund, which is based on the…

Contact Author

Ronald-Peter Stoferle

Ronald-Peter Stoferle

Incrementum AG

Ronald, born 1980 in Vienna, Austria, is a Chartered Market Technician (CMT) and a Certified Financial Technician (CFTe). During his studies in business administration and…

Contact Author

  1. Home
  2. Markets
  3. Other

In Gold We Trust 2016 - Compact Version

Gold is back! With the strongest quarterly performance in 30 years, the precious metal in Q1 2016 emerged from the bear market that had been in force since 2013. A decisive factor in this comeback is growing uncertainty over the recovery of the post-Lehman economy. After years of administering high doses of monetary painkillers, will the Fed succeed in discontinuing the practice? Or is the entire therapy about to be fundamentally questioned?

In Gold We Trust 2016 - Compact Version

The extended version is available at http://www.incrementum.li/en/research-analysis/in-gold-we-trust-2016/

 

Read the Report

Back to homepage

Leave a comment

Leave a comment